IMPROVEMENT STRATEGIES IN QUALITY PRESCRIBING INDICATORS ON A HEALTHCARE AREA
DI-020
EFFECTIVENESS OF SORAFENIB IN ADVANCED HEPATOCELLULAR CARCINOMA IN REAL-LIFE CONDITIONS
DI-019
STUDY OF ADHERENCE TO THE USE OF INHALED COLISTIN
DI-018
SIMPLIFICATION TO SINGLE-DRUG REGIMEN WITH A RITONAVIR-BOOSTED PROTEASE INHIBITOR FOR HIV PATIENTS
CP-017
USAGE PROFILE, EFFECTIVENESS AND SAFETY OF COFORMULATED RILPIVIRINE/EMTRICITABINE/TENOFOVIR
DI-015
EVALUATION OF PHARMACOLOGICAL PAIN CONTROL MANAGEMENT IN CANCER PATIENTS; A PATIENT-CENTERED APPROACH TO PREVENT EXPOSURE TO INEFFECTIVE MEDICATION
DI-014
OFF LABEL USE AND ECONOMIC IMPACT OF BIOLOGIC THERAPY IN NON-INFECTIOUS UVEITIS
DI-012
RITUXIMAB EFFICACY IN THE TREATMENT OF AUTOIMMUNE DISEASES
DI-010
FACTORS INFLUENCING THE APPEARANCE OF HAEMATOLOGICAL AND THYROID ADVERSE EFFECTS IN PATIENTS WITH HEPATITIS C VIRUS GENOTYPE 1 TREATED WITH TELAPREVIR/BOCEPREVIR PLUS PEG-INTERFERON AND RIBAVIRIN
DI-009
VITAMIN K ANTAGONIST / NEW ORAL ANTICOAGULANT IN ATRIAL FIBRILLATION: MONITORING OF HAEMORRHAGIC RISK
DI-008
EVALUATING THE LEVEL OF KNOWLEDGE OF MEDICINES AND NEED FOR INFORMATION AMONG PEOPLE CARING FOR PAEDIATRIC CANCER PATIENTS
DI-005
RESPONSE TO REPLACEMENT ENZYME TREATMENT IN PATIENTS WITH TYPE 1 GAUCHER'S DISEASE
DI-004
STUDY ON PRESCRIPTION PATTERN AND COST ANALYSIS OF ANTIRETROVIRAL DRUGS IN A TERTIARY CARE HOSPITAL.
DI-003
EVALUATION OF PROFESSIONAL PRACTICE ON THE MANAGEMENT OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING
DI-058
Experience in paediatric use of dapsone for the treatment of linear IGA dermatosis
